Comparison of broad-spectrum antiviral activities of the synthetic rocaglate CR-31-B (−) and the eIF4A-inhibitor Silvestrol

Christin Müller, Wiebke Obermann, Falk W. Schulte, Kerstin Lange‐Grünweller, Lisa Oestereich, Fabian Elgner, Mirco Glitscher, Eberhard Hildt, Kamini Singh, Hans-Guido Wendel, Roland K. Hartmann, John Ziebuhr, Arnold Grünweller